SURG SYNERGETICS USA INC

Nasdaq http://www.synergeticsusa.com


$ 2.75 $ 0.02 (0.73 %)    

Friday, 24-Oct-2025 15:59:51 EDT
QQQ $ 617.50 $ 6.52 (1.07 %)
DIA $ 472.45 $ 4.92 (1.05 %)
SPY $ 677.25 $ 5.49 (0.82 %)
TLT $ 91.47 $ 0.04 (0.04 %)
GLD $ 378.59 $ -1.27 (-0.34 %)
$ 2.75
$ 2.73
$ 2.51 x 300
$ 3.00 x 272
$ 2.67 - $ 2.75
$ 1.05 - $ 3.47
53,676
na
70.32M
$ 1.86
$ 15.70
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 10-14-2015 07-31-2015 10-K
2 06-09-2015 04-30-2015 10-Q
3 03-10-2015 01-31-2015 10-Q
4 12-10-2014 10-31-2014 10-Q
5 10-14-2014 07-31-2014 10-K
6 06-09-2014 04-30-2014 10-Q
7 03-06-2014 01-31-2014 10-Q
8 12-09-2013 10-31-2013 10-Q
9 10-01-2013 07-31-2013 10-K
10 06-10-2013 04-30-2013 10-Q
11 03-12-2013 01-31-2013 10-Q
12 12-10-2012 10-31-2012 10-Q
13 10-15-2012 07-31-2012 10-K
14 06-11-2012 04-30-2012 10-Q
15 03-12-2012 01-31-2012 10-Q
16 12-12-2011 10-31-2011 10-Q
17 10-11-2011 07-31-2011 10-K
18 06-07-2011 04-30-2011 10-Q
19 03-09-2011 01-31-2011 10-Q
20 12-14-2010 10-31-2010 10-Q
21 10-12-2010 07-31-2010 10-K
22 06-14-2010 04-30-2010 10-Q
23 03-17-2010 01-31-2010 10-Q
24 12-15-2009 10-31-2009 10-Q
25 10-28-2009 07-31-2009 10-K
26 06-15-2009 05-04-2009 10-Q
27 03-16-2009 02-03-2009 10-Q
28 12-08-2008 10-29-2008 10-Q
29 10-14-2008 07-31-2008 10-K
30 06-09-2008 04-30-2008 10-Q
31 03-11-2008 01-31-2008 10-Q
32 12-10-2007 10-29-2007 10-Q
33 10-15-2007 07-31-2007 10-K
34 06-08-2007 04-30-2007 10-Q
35 03-09-2007 01-30-2007 10-Q
36 12-08-2006 10-29-2006 10-Q
37 10-16-2006 07-31-2006 10-K
38 06-13-2006 04-30-2006 10-Q
39 03-15-2006 01-30-2006 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 surgepays-estimates-revenue-for-q3-2025-to-increase-sequentially-over-60-affirms-fy26-revenue-guidance-of-225m

Focused execution across multiple revenue channels with Lifeline providing the quickest path to near-term profitability and Cle...

 ascendiant-capital-maintains-buy-on-surgepays-raises-price-target-to-95

Ascendiant Capital analyst Edward Woo maintains Surgepays (NASDAQ:SURG) with a Buy and raises the price target from $9 to $9.5.

 surgepays-cfo-anthony-evers-to-exit-role-as-employment-contract-set-to-expire-december-31-2025

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arra...

 surgepays-sees-fy2025-sales-75000m-90000m-vs-94162m-est

Surgepays (NASDAQ:SURG) sees FY2025 sales of $75.000 million-$90.000 million vs $94.162 million analyst estimate.

 surgepays-q2-eps-036-misses-020-estimate-sales-11518m-miss-16137m-estimate

Surgepays (NASDAQ:SURG) reported quarterly losses of $(0.36) per share which missed the analyst consensus estimate of $(0.20) b...

 surgepays-enters-atm-agreement-with-titan-partners-may-offer-shares-up-to-15m

 - SEC Filing

 ascendiant-capital-maintains-buy-on-surgepays-raises-price-target-to-9

Ascendiant Capital analyst Edward Woo maintains Surgepays (NASDAQ:SURG) with a Buy and raises the price target from $8.75 to...

 surgepays-q1-eps-038-misses-023-estimate-sales-1058m-miss-1218m-estimate

Surgepays (NASDAQ:SURG) reported quarterly losses of $(0.38) per share which missed the analyst consensus estimate of $(0.23) b...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION